Compare uniQure N.V. Ordinary Shares (QURE) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs iShares 10 20 Year Treasury Bond ETF — how do they compare? uniQure N.V. Ordinary Shares trades at $21.53 (market cap $1.45B), while iShares 10 20 Year Treasury Bond ETF trades at $94.4 (market cap $11.48B). The key difference: iShares 10 20 Year Treasury Bond ETF is far larger — about 7.9× uniQure N.V. Ordinary Shares's market cap, and uniQure N.V. Ordinary Shares is more actively traded (3,323,243 versus 3,119,674). Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and iShares 10 20 Year Treasury Bond ETF for 62 Days on average.
| QURE | TLH | |
|---|---|---|
Market Cap | $1.45B | $11.48B |
Volume | 3,323,243 | 3,119,674 |
Sector | Health | Fixed Income |
52-Week High | $70.59 | $105.36 |
52-Week Low | $9.03 | $91.34 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $707.46M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLH, the iShares 10-20 Year Treasury Bond ETF, trades at $92.56 with a slight 0.34% daily gain amid a challenging bond market environment. Technical indicators signal a bearish trend with selling pressure outweighing buying signals. Recent trading volume spikes indicate heightened investor interest as Treasury yields reach multi-decade highs, creating volatility for long-duration bond ETFs.
The outlook remains cautious as rising interest rates pressure bond prices, though the ETF provides exposure to US Treasury securities. Key risks include continued Fed tightening and inflation concerns, while potential stabilization in yields could offer support. Institutional activity shows mixed positioning with some funds reducing exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About iShares 10 20 Year Treasury Bond ETF
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →
